TOBI is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Tobramycin.
Product ID | 0078-0494_cb71e4dc-f6a7-455f-b72c-78cb8a4d3fee |
NDC | 0078-0494 |
Product Type | Human Prescription Drug |
Proprietary Name | TOBI |
Generic Name | Tobramycin |
Dosage Form | Solution |
Route of Administration | ORAL |
Marketing Start Date | 1997-12-22 |
Marketing Category | NDA / NDA |
Application Number | NDA050753 |
Labeler Name | Novartis Pharmaceuticals Corporation |
Substance Name | TOBRAMYCIN |
Active Ingredient Strength | 300 mg/5mL |
Pharm Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1997-12-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050753 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2014-07-02 |
Marketing Category | NDA |
Application Number | NDA050753 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1997-12-22 |
Marketing Category | NDA |
Application Number | NDA050753 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1997-12-22 |
Ingredient | Strength |
---|---|
TOBRAMYCIN | 300 mg/5mL |
SPL SET ID: | 94f9e516-6bf6-4e30-8dde-8833c25c2560 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0078-0494 | TOBI | Tobramycin |
10122-820 | BETHKIS | tobramycin |
0078-0630 | TOBI Podhaler | Tobramycin |
0093-3750 | Tobramycin | Tobramycin |
0093-4085 | Tobramycin | Tobramycin |
0404-7196 | Tobramycin | Tobramycin |
0409-3578 | TOBRAMYCIN | TOBRAMYCIN |
0703-9402 | Tobramycin | Tobramycin |
0781-7171 | Tobramycin | Tobramycin |
10544-883 | Tobramycin | Tobramycin |
13985-604 | Tobramycin | Tobramycin |
13985-743 | Tobramycin | Tobramycin |
17478-290 | Tobramycin | Tobramycin |
17478-340 | Tobramycin | Tobramycin |
0065-0643 | Tobrex | tobramycin |
0065-0644 | TOBREX | tobramycin |
0078-0813 | TOBREX | tobramycin |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TOBI 98829213 not registered Live/Pending |
Tobi, Inc. 2024-10-30 |
TOBI 97669601 not registered Live/Pending |
SCSE HOME LLC 2022-11-09 |
TOBI 90784685 not registered Live/Pending |
HCW Biologics, Inc. 2021-06-21 |
TOBI 90123270 not registered Live/Pending |
Wei, Chao 2020-08-19 |
TOBI 88847929 not registered Live/Pending |
MGA Entertainment, Inc. 2020-03-25 |
TOBI 85931463 not registered Dead/Abandoned |
Novartis AG 2013-05-14 |
TOBI 85746006 4983442 Live/Registered |
Little Airplane Productions, Inc. 2012-10-04 |
TOBI 85170184 4028028 Dead/Cancelled |
The Oncology Business Institute 2010-11-05 |
TOBI 85145153 4488766 Live/Registered |
BGP PRODUCTS OPERATIONS GMBH 2010-10-05 |
TOBI 79352748 not registered Live/Pending |
Nicole Bongartz 2022-09-16 |
TOBI 78857304 3280946 Live/Registered |
TOBI PRODUCTS, INC. 2006-04-09 |
TOBI 78434648 3406527 Live/Registered |
Tobi, LLC 2004-06-14 |